Xcout Intel
Ollin Bio
Ollin Biosciences is a clinical-stage biopharmaceutical holding company established in 2023 and headquartered in Austin, Texas, dedicated to developing therapeutics.
Subscribe to see Ollin Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Ollin Bio at a glance
Ollin Bio is a biotechnology company headquartered in United States. Its most recent funding round, Series B, raised $330M in June 2026. Xcout tracks 1 named person at Ollin Bio, including Jason Ehrlich (Co-founder and Chief Executive Officer).
Ollin Bio leadership
- Jason EhrlichCo-founder and Chief Executive Officer
Ollin Bio funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $330M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Ollin Bio competitors
A few of Ollin Bio's closest competitors — see the full list of competitors and alternatives →
Mati Therapeutics Inc. is a development-stage company headquartered in Austin, Texas, focused on developing therapeutic products.
Tempero Bio, Inc. is a clinical-stage biopharmaceutical holding company established in 2020 and headquartered in Oakland, California. The company focuses on developing transformative therapeutics and advancing its drug pipeline through clinical trials.
Allink Biotherapeutics is a clinical-stage biotechnology company founded in 2023 and based in Shanghai, China, focused on developing advanced antibody-drug conjugates (ADCs) and therapeutics.
Pathios Therapeutics Limited is a biotech company established in 2017 and registered in England and Wales, focusing on the discovery and development of first-in-class therapies.
Iterion Therapeutics is a clinical-stage biopharmaceutical company headquartered in Houston, Texas. Founded in 2015, the company is dedicated to revolutionizing healthcare through novel drug discovery and innovation.
Oxalo Therapeutics, Inc. is a privately held biotechnology and therapeutics company founded in 2018 and based in Chicago, Illinois, dedicated to developing first-in-class treatments to treat and prevent disease targets.
Get Ollin Bio's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Ollin Bio in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access